Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yimenashu Mamo Kassaye"'
Autor:
Abrha G. Gebrehiwot, Daniel Seifu Melka, Yimenashu Mamo Kassaye, Tufa Gemechu, Wajana Lako, Hiroshi Hinou, Shin-Ichiro Nishimura
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-18 (2019)
Abstract Background Alterations in protein glycosylation patterns have potentially been targeted for biomarker discovery in a wide range of diseases including cancer. Although there have been improvements in patient diagnosis and survival for breast
Externí odkaz:
https://doaj.org/article/0129004bc2234bdb9f7c75fe329cb3cd
Autor:
Abrha G Gebrehiwot, Daniel Seifu Melka, Yimenashu Mamo Kassaye, Ibrahim F Rehan, Shobith Rangappa, Hiroshi Hinou, Toshiya Kamiyama, Shin-Ichiro Nishimura
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209515 (2018)
BackgroundMost glycomics studies have focused on understanding disease mechanisms and proposing serum markers for various diseases, yet the influence of ethnic variation on the identified glyco-biomarker remains poorly addressed. This study aimed to
Externí odkaz:
https://doaj.org/article/dd18d0f9ddb143419eb0491cf549bd2b
Autor:
Wajana Lako, Tufa Gemechu, Shin-Ichiro Nishimura, Daniel Seifu Melka, Abrha G. Gebrehiwot, Yimenashu Mamo Kassaye, Hiroshi Hinou
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-18 (2019)
BMC Cancer
BMC Cancer
Background Alterations in protein glycosylation patterns have potentially been targeted for biomarker discovery in a wide range of diseases including cancer. Although there have been improvements in patient diagnosis and survival for breast cancer (B
Autor:
Daniel Seifu Melka, Toshiya Kamiyama, Abrha G. Gebrehiwot, Shin-Ichiro Nishimura, Yimenashu Mamo Kassaye, Ibrahim F. Rehan, Shobith Rangappa, Hiroshi Hinou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0209515 (2018)
PLoS ONE, Vol 13, Iss 12, p e0209515 (2018)
BackgroundMost glycomics studies have focused on understanding disease mechanisms and proposing serum markers for various diseases, yet the influence of ethnic variation on the identified glyco-biomarker remains poorly addressed. This study aimed to